Methods |
Identification of subsequent full‐length publications
|
Data |
|
Comparisons |
Proportion of abstracts published
'Positive' versus not 'positive'
Sample size more than 500 versus between 50 and 500 versus less than 50
Oral versus poster presentation
International versus European Union country versus non‐European Union country versus non‐European country
'Treatment concealed' versus no 'treatment concealed' published
RCT design versus non‐RCT design
|
Outcomes |
34 of 128 abstracts published
Proportion of abstracts published by time not reported
-
Factors related to proportion of abstracts published included
25/93 'positive' (not defined) versus 9/35 not 'positive' abstract results published
5/19 abstracts with sample size greater than 500 versus 16/47 abstracts with sample size between 50 and 500 versus 13/62 abstracts with sample size below 50 published
6/15 abstracts presented orally versus 28/115 abstracts presented as poster published
15/28 abstracts with an international origin versus 13/57 abstracts originating from a single European Union country versus 2/18 abstracts originating from a single non‐European Union country versus 4/25 abstracts originating from outside Europe published
17/43 abstracts with 'treatment concealed' versus 14/71 abstracts without 'treatment concealed' published
24/65 abstracts with RCT design versus 10/52 abstracts with non‐RCT design published
|
Notes |
|
Risk of bias |
Item |
Authors' judgement |
Description |
Sampling method? |
Yes |
Included all abstracts. |
Search for publications? |
No |
Searched only 1 database. |
Follow‐up time? |
No |
All meetings had less than 48 months follow‐up. |
Matching? |
Unclear |
Matching criteria not reported. |
Adjustment for confounding? |
No |
Examined association of positive results, sample size, type presentation, European origin, study design, and 'treatment concealment' with publication using stratified analysis and unspecified. statistical tests. |